Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan · Delayed Price · Currency is TWD

41.80

-0.45 (-1.07%)

Feb 11, 2026, 1:30 PM CST

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
New Drug Development	167.57M
New Drug Development Growth	-46.72%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	167.49M
United States Growth	-46.74%
Taiwan	75.00K